Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
ProShares UltraPro Short S&P500 ETF
SPXU
5
Tradr 2X Short TSLA Daily ETF
TSLQ
US Stock MarketDetailed Quotes
CORT Corcept Therapeutics
- 71.880
- -1.350-1.84%
Close Apr 30 16:00 ET
- 73.150
- +1.270+1.77%
Post 17:12 ET
7.62BMarket Cap58.44P/E (TTM)
73.120High70.950Low810.04KVolume73.120Open73.230Pre Close58.24MTurnover0.93%Turnover Ratio58.44P/E (Static)106.04MShares117.33052wk High11.22P/B6.29BFloat Cap23.02052wk Low--Dividend TTM87.49MShs Float117.330Historical High--Div YieldTTM2.96%Amplitude0.680Historical Low71.893Avg Price1Lot Size
Corcept Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 4.10%383.33M | 4.10%383.33M | 7.07%380.34M | 30.25%473.16M | -11.68%410.76M | -14.70%368.22M | -14.70%368.22M | -10.36%355.23M | -1.84%363.26M | 34.59%465.06M |
| -Cash and cash equivalents | -5.82%127.67M | -5.82%127.67M | 22.80%137.29M | -25.40%128.59M | -50.07%149.75M | 104.36%135.55M | 104.36%135.55M | 122.52%111.8M | 387.68%172.38M | 384.86%299.94M |
| -Short-term investments | 9.88%255.67M | 9.88%255.67M | -0.16%243.05M | 80.51%344.57M | 58.08%261.01M | -36.31%232.67M | -36.31%232.67M | -29.65%243.43M | -42.98%190.89M | -41.79%165.12M |
| Receivables | -2.08%53.98M | -2.08%53.98M | 22.81%59.72M | 15.65%53.84M | 32.13%61.52M | 22.34%55.12M | 22.34%55.12M | 65.32%48.63M | 65.29%46.55M | 71.30%46.56M |
| -Accounts receivable | 31.26%53.98M | 31.26%53.98M | 72.46%59.72M | 65.38%53.84M | 88.95%61.52M | 32.41%41.12M | 32.41%41.12M | 17.72%34.63M | 15.58%32.55M | 19.79%32.56M |
| -Other receivables | ---- | ---- | ---- | ---- | ---- | 0.00%14M | 0.00%14M | --14M | --14M | --14M |
| Inventory | 60.57%12.41M | 60.57%12.41M | 7.15%8.05M | 20.75%8.35M | 12.19%7.19M | 26.72%7.73M | 26.72%7.73M | 24.26%7.51M | 27.18%6.92M | 26.19%6.41M |
| Prepaid assets | 38.18%11.31M | 38.18%11.31M | --8.59M | --8.05M | --5.54M | --8.18M | --8.18M | ---- | ---- | ---- |
| Current deferred assets | -66.71%4.49M | -66.71%4.49M | --5.71M | --8.33M | ---- | --13.5M | --13.5M | ---- | ---- | ---- |
| Other current assets | 3.33%6.08M | 3.33%6.08M | -77.29%4.58M | -42.45%9.13M | 15.66%18.36M | -64.19%5.88M | -64.19%5.88M | --20.16M | --15.86M | --15.87M |
| Total current assets | 2.83%471.6M | 2.83%471.6M | 8.22%466.98M | 29.65%560.85M | -5.72%503.37M | -8.14%458.64M | -8.14%458.64M | -4.61%431.53M | 3.23%432.59M | 37.52%533.89M |
| Non current assets | ||||||||||
| Net PPE | 2,443.81%8.01M | 2,443.81%8.01M | 1,656.88%8.43M | 1,004.32%7.16M | -81.85%188K | -82.26%315K | -82.26%315K | -80.86%480K | -79.27%648K | -70.75%1.04M |
| -Gross PPE | 2,443.81%8.01M | 2,443.81%8.01M | 1,656.88%8.43M | 51.84%7.16M | -96.17%188K | -82.26%315K | -82.26%315K | -92.04%480K | -26.99%4.71M | -27.24%4.92M |
| -Accumulated depreciation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -22.11%-4.07M | -20.73%-3.88M |
| Investments and advances | 284.48%219.83M | 284.48%219.83M | 180.62%167.31M | --19.32M | --40.28M | 1,055.77%57.18M | 1,055.77%57.18M | 1,118.00%59.62M | --0 | --0 |
| Non current deferred assets | 44.49%130.91M | 44.49%130.91M | 45.58%126.8M | 43.00%111.85M | 43.93%97.87M | 47.41%90.61M | 47.41%90.61M | 51.90%87.1M | 61.30%78.21M | 80.31%68M |
| Other non current assets | -31.06%10.19M | -31.06%10.19M | -3.63%14.74M | 16.81%15.39M | -4.60%14.23M | -7.53%14.79M | -7.53%14.79M | -5.07%15.29M | -4.61%13.18M | -7.23%14.92M |
| Total non current assets | 126.52%368.95M | 126.52%368.95M | 95.25%317.28M | 67.01%153.71M | 81.73%152.57M | 93.50%162.88M | 93.50%162.88M | 100.98%162.5M | 19.04%92.04M | 5.07%83.96M |
| Total assets | 35.24%840.55M | 35.24%840.55M | 32.02%784.26M | 36.20%714.56M | 6.16%655.94M | 6.53%621.52M | 6.53%621.52M | 11.40%594.02M | 5.69%524.63M | 31.98%617.85M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -23.27%15.57M | -23.27%15.57M | -61.21%18.58M | -32.30%19.48M | 36.39%27.01M | 68.16%20.29M | 68.16%20.29M | 485.85%47.91M | 249.02%28.78M | -4.75%19.81M |
| -accounts payable | -11.61%15.38M | -11.61%15.38M | 11.21%18.58M | 144.28%19.48M | 11.96%12.56M | 45.26%17.4M | 45.26%17.4M | 104.33%16.71M | -3.27%7.98M | 21.01%11.22M |
| -Total tax payable | -93.40%191K | -93.40%191K | ---- | ---- | 68.30%14.46M | 3,149.44%2.89M | 3,149.44%2.89M | --31.2M | --20.8M | -25.46%8.59M |
| Current accrued expenses | -1.76%38.79M | -1.76%38.79M | -15.84%33.53M | -23.72%26.88M | -7.40%31.47M | 23.74%39.49M | 23.74%39.49M | 117.25%39.84M | 106.87%35.24M | 101.75%33.98M |
| Current debt and capital lease obligation | 449.01%829K | 449.01%829K | 92.00%432K | -85.19%44K | -86.78%76K | -86.79%151K | -86.79%151K | -86.82%225K | -86.88%297K | -74.60%575K |
| -Current capital lease obligation | 449.01%829K | 449.01%829K | 92.00%432K | -85.19%44K | -86.78%76K | -86.79%151K | -86.79%151K | -86.82%225K | -86.88%297K | -74.60%575K |
| Current deferred liabilities | 125.15%41.58M | 125.15%41.58M | 166.73%38.8M | 103.90%31.65M | 77.92%27.54M | 66.41%18.47M | 66.41%18.47M | 24.51%14.55M | 29.20%15.52M | 25.05%15.48M |
| Other current liabilities | 247.40%2.27M | 247.40%2.27M | 691.12%7.3M | 730.09%5.3M | ---- | -14.29%654K | -14.29%654K | 6.95%923K | 2.41%638K | --1.22M |
| Current liabilities | 34.70%140.77M | 34.70%140.77M | 3.56%126.22M | 8.26%100.75M | 23.25%97.2M | 44.16%104.51M | 44.16%104.51M | 129.65%121.87M | 89.70%93.06M | 37.77%78.87M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --6.11M | --6.11M | --6.36M | --5.63M | ---- | --0 | --0 | ---- | ---- | ---- |
| -Long term capital lease obligation | --6.11M | --6.11M | --6.36M | --5.63M | ---- | --0 | --0 | ---- | ---- | ---- |
| Total non current liabilities | 95.90%20.19M | 95.90%20.19M | 83.44%19.21M | 76.47%17.56M | 15.64%10.87M | 13.30%10.31M | 13.30%10.31M | 53.45%10.47M | 99.80%9.95M | 206.36%9.4M |
| Total liabilities | 40.20%160.96M | 40.20%160.96M | 9.88%145.42M | 14.85%118.31M | 22.44%108.07M | 40.72%114.81M | 40.72%114.81M | 120.97%132.34M | 90.63%103.01M | 46.35%88.26M |
| Shareholders'equity | ||||||||||
| Share capital | 2.26%136K | 2.26%136K | 1.50%135K | 1.52%134K | 1.53%133K | 1.53%133K | 1.53%133K | 2.31%133K | 3.13%132K | 2.34%131K |
| -common stock | 2.26%136K | 2.26%136K | 1.50%135K | 1.52%134K | 1.53%133K | 1.53%133K | 1.53%133K | 2.31%133K | 3.13%132K | 2.34%131K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | 35.08%543.74M | 35.08%543.74M | 38.21%512.99M | 37.08%465.78M | 37.80%430.29M | 35.81%402.53M | 35.81%402.53M | 32.66%371.17M | 38.59%339.79M | 43.40%312.27M |
| Paid-in capital | 12.67%832.11M | 12.67%832.11M | 11.62%806.32M | 12.26%781.01M | 11.53%758.24M | 11.50%738.52M | 11.50%738.52M | 11.34%722.4M | 11.14%695.72M | 11.69%679.85M |
| Less: Treasury stock | 9.62%696.17M | 9.62%696.17M | 7.98%682.18M | 5.97%650.76M | 38.61%641.06M | 39.23%635.08M | 39.23%635.08M | 39.47%631.79M | 43.87%614.07M | 10.79%462.51M |
| Gains losses not affecting retained earnings | -135.63%-217K | -135.63%-217K | 771.37%1.57M | 86.67%84K | 268.63%258K | 170.08%609K | 170.08%609K | 90.17%-234K | 102.10%45K | 88.68%-153K |
| Total stockholders'equity | 34.12%679.59M | 34.12%679.59M | 38.37%638.84M | 41.42%596.24M | 3.45%547.86M | 0.97%506.71M | 0.97%506.71M | -2.47%461.68M | -4.68%421.61M | 29.86%529.58M |
| Total equity | 34.12%679.59M | 34.12%679.59M | 38.37%638.84M | 41.42%596.24M | 3.45%547.86M | 0.97%506.71M | 0.97%506.71M | -2.47%461.68M | -4.68%421.61M | 29.86%529.58M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now